GNLX Stock Price | Analyst Target 18.00 & Moderate Buy Consensus

Genelux Corporation GNLX

‎$‎2.06-0.01(-0.48%)(1D)

• Delayed prices byNASDAQ • in USD

Analyst Forecast

Consensus
Moderate Buy

Price Target
18.00
Based on analysts who covered GNLX

GNLX Stock Price Chart

‎-18.58‎
Past Month
1D
1W
1M
6M
1Y
3Y
MAX

The Genelux Corporation share price is on the decline this week.

The Genelux Corporation share price today is ‎$‎2.06, reflecting a ‎-0.48‎% change over the last 24 hours and ‎-11.21‎% over the past week. The current market capitalization of GNLX is ‎$‎93.66M with an average volume in the last three months of 301595.11. The stock has a P/E ratio of -2.39 and a dividend yield of 0%.
With the stock’s beta sitting at 1.57

GNLX Key Metrics

Market Cap
‎$‎93.66M

Day’s Range
‎$‎2 -‎$‎2.53

52W Range
‎$‎2 -‎$‎8.46

Average Volume (3M)
301595.11

Price-Earnings Ratio
-2.39

Revenue
‎$‎8000

Dividend (Yield)
‎$‎0 (0%)

Prev Close
‎$‎2.07

EPS
‎$‎-0.87

Beta
1.57

How can I buy Genelux Corporation stocks?

To purchase Genelux Corporation:

01

Create an eToro account:

Sign up for an eToro account and verify your identity.

02

Deposit funds:

Deposit funds into your eToro account using your preferred payment method.

03

Search and purchase:

Search the Genelux Corporation (GNLX) page and place an order to buy Genelux Corporation.

What Is Genelux Corporation?

Genelux Corporation is a biopharmaceutical company recognised for its breakthrough strategies in virotherapy and viral oncotherapy.
The US-based company strives to create therapeutic solutions to combat cancer and other inflammatory diseases.
The company employs its innovative development method in the healthcare and biotechnology sector, specialising in healthcare services, cancer treatment and genetic medicine.
The company’s lead product candidate is Olvi-Vic, a proprietary, modified strain of the vaccinia virus used in the treatment of ovarian cancer and non-small-cell lung cancer.

CEO
Thomas D. Zindrick

Employees
26

Founded
2001

HQ
Westlake Village, California, US

FAQ

What is the current price of Genelux Corporation stock?
The current price of GNLX is ‎$‎2.06.

What is Genelux Corporation’s stock future price target?
The average price target for Genelux Corporation is ‎$‎18.00.

What are analysts’ forecasts for Genelux Corporation?
Analysts offer forecasts for Genelux Corporation based on market trends, financial reports and projected growth.

What is the market cap of Genelux Corporation?
The market capitalisation of Genelux Corporation is ‎$‎93.66M

Is Genelux Corporation stock buy, sell or hold?
Based on 1 analysts offering recommendations for GNLX in the last 3 months, the overall consensus is Moderate Buy.